Global Renal Biomarkers Market (2017-2022): Regulatory & Reimbursement Policies Limit Growth - Research and Markets

DUBLIN--()--The "Global Renal Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)" report has been added to Research and Markets' offering.

The market growth is majorly driven by the increasing prevalence of various kidney-related diseases. The high prevalence of diabetes and high blood pressure are also accelerating the market, as they can lead to renal diseases. Other prominent growth factors include rapid technological advances in genetics, which is leading to the discovery of novel biomarkers, and the increasing need to personalize medicine for patients, to decrease treatment costs. However, the market is restrained due to issues with the regulatory and reimbursement policies.

The global renal biomarkers market is segmented into biomarker type, diagnostic technique, type of end-user and geography. Based on the type of biomarker, the market is segmented into functional biomarkers, up-regulated proteins and other types. The functional biomarkers segment is further segmented into serum creatinine, serum cystatin c, urine albumin; the up-regulated proteins segment is further divided into neutrophil gelatinase-associated lipocalin, kidney injury molecule - 1 and interleukin 18.

Further, based on the diagnostic technique, the market is segmented into enzyme linked immunosorbent assay, particle-enhanced turbid metric immunoassay, colorimetric assay and others. The market is segmented, by the end-user type, into diagnostic labs, outpatient clinics, research centers & hospitals.

Companies Mentioned:

  • Beckman Coulter, Inc.
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Bioporto
  • Astute Medical, Inc.
  • Randox Laboratories Ltd.
  • Siemens Healthcare Diagnostics, Inc.
  • Alere, Inc.
  • F. Hoffmann-La Roche AG
  • BioMrieux SA
  • Others

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Market Dynamics

7. Market Segmentation by Biomarker Type

8. Market Segmentation by Diagnostic Technique

9. Market Segmentation By End User

10. Market Segmentation by geography

11. Competitive Landscape

12. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/njh8lp/global_renal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomarkers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomarkers